Effect of Paricalcitol Over Vessel Wall

Stopped Protocol showed to be inappropriate for the evaluation of the selected patients

Conditions

• Nephropathy

Interventions

• DRUG: Paricalcitol

Sponsor

Effice Servicios Para la Investigacion S.L.

Collaborators

• [object Object]